Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can lifestyle choices after a stroke extend life and prevent a second one?

NCT ID NCT03962127

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study follows 800 adults who have had their first ischemic stroke in Central Norway for up to 10 years. Researchers will track how physical activity, medication use, and control of blood pressure and cholesterol affect the risk of death, another stroke, or severe disability. The goal is to find ways to improve stroke care and help survivors live longer with a better quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could reveal which lifestyle factors and medication targets most improve long-term outcomes after a first stroke, potentially guiding more effective rehabilitation and prevention strategies.
What could go wrong
As an observational study, it cannot prove cause and effect. Results may be influenced by unmeasured factors, and the findings might not apply to stroke patients outside Central Norway.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

800 people

The number who actually took part.

Started

May 2015

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients treated in a hospital in Central Norway for first time ischemic stroke.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Cerebral infarction according to ICD-10 CM code I63 * \> 18 years of age * First time stroke resident in Central-Norway * Recruited within a time frame of 7 days of hospital admission. Exclusion criteria: * Focal neurological symptoms turned out to be not stroke-related * Significant physical disabilities prior to stroke (defined as Modified Rankin ≥5).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain ischemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kristiansund Sykehus

    Kristiansund, Norway

  • Levanger Sykehus

    Levanger, Norway

  • Molde Sykehus

    Molde, Norway

  • Namsos Sykehus

    Namsos, Norway

  • Orkdal Sykehus

    Orkanger, Norway

  • St Olavs Hospital

    Trondheim, Norway

  • Volda Sykehus

    Volda, Norway

  • Ålesund Sykehus

    Ålesund, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.